Interview: Smart for Life (SMFL) CEO A.J. Cervantes.

Excellent interview. We were at the Noble Investor Conference to see it live. And we were at the manufacturing plant this Friday....
Mitesco

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.

LIVE QUOTE Mitesco, Inc. (MITI) is building a better model...

Adding Smart for Life (SMFL) $0.85 to the Watch List.

Adding another "Broken" IPO to the Watch List. We're not sure if "broken" is the appropriate description, when...

Beachbody (BODY) Conference Call

"Make no mistake, as the single largest shareholder as well as CEO of Beachbody, but more so because I believe in the...

Adding Beach Body (BODY) $3.90 to the Watch List.

This is Like Shooting Fish in the Barrell, but the Fish Shoot Back. We’re not traders, but we...

Nautilus (NLS) $8.50, Numbers Out. Time to go Bottom Fishing?

Adding Nautilus to the Watch List. Conference Call Transcript Below New Street Targets at $15 per Share.
Internet Stock Review

Peloton Plunges $9 Billion in Value, on a $805 Million Quarter!

Peloton just reported the $805 million for three months worth of business ended September. That's $9 million worth of fitness everyday. And...

Telehealth Watch List.

We Haven't Looked at the Telehealth Watch List for a Spell and we Were Very Surprised at the YTD Performance.

Hapbee’s (HAPB) TV Series, to Air Over Syndicated Television Networks.

New to The Street TV and Hapbee Technologies, Inc. Sign Contract for 12 Part TV Series Across Syndicated Television Networks

Hapbee (HAPB) Adds 18 New Signal Blends in Major Expansion of Its Digital Wellness...

Hapbee now comes bundled with "lifetime blends" and offers an all-access subscription option. VANCOUVER, BC, Sept. 20, 2021 /PRNewswire/ - Hapbee Technologies,...

Latest article

Smart for Life (SMFL) Capitulates?

We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...